生命早期抗生素暴露与6~23月龄儿童过敏症状的出生队列研究
基于马鞍山1 558对母子的前瞻性出生队列,分析孕期及1岁内抗生素暴露与6~11月龄、18~23月龄儿童过敏症状的关联。调整多项混杂因素后,婴儿期多个时段抗生素使用与两个年龄点过敏症状风险升高相关,提示婴儿期应避免不必要抗生素使用。
要点
- 婴儿期抗生素暴露与6~11月龄及18~23月龄过敏症状风险升高相关。
- 3~5月龄与6~11月龄抗生素使用是6~11月龄过敏症状的危险因素。
- 0~2月龄、3~5月龄与6~11月龄抗生素使用是18~23月龄过敏症状的危险因素。
核心结论
- 儿童1岁内抗生素暴露是其在6~11月龄和18~23月龄发生过敏性疾病的危险因素,婴儿期应尽量避免不必要的抗生素使用。
研究设计与样本
- 采用前瞻性出生队列研究,2015年6月至2016年6月在马鞍山市妇幼保健院纳入2 122名孕妇,随访至儿童24月龄。
- 排除失访及信息不完整的564对母子后,共1 558对母子纳入分析。
- 过敏症状信息参考国际间儿童哮喘及其他过敏性疾病的对比研究(ISAAC)调查,采用单因素和多因素二分类非条件logistic回归分析。
主要发现
- 孕妇孕期抗生素使用率为3.4%(53名)。
- 儿童0~2月龄、3~5月龄、6~11月龄抗生素使用率分别为15.2%(237名)、15.5%(242名)、17.3%(269名)。
- 6~11月龄儿童过敏性疾病总患病率为24.1%(375名),18~23月龄为22.0%(342名)。
关键数值与推荐
- 调整父(母)亲文化程度、家庭人均月收入、父(母)亲过敏史、妊娠时父(母)亲年龄、母亲孕前BMI、孕期二手烟暴露、分娩方式、儿童性别、出生体重、早产后:3~5月龄抗生素使用(RR=1.61,95%CI:1.19~2.17)和6~11月龄抗生素使用(RR=1.43,95%CI:1.06~1.93)是6~11月龄过敏症状的危险因素。
- 0~2月龄(RR=1.41,95%CI:1.03~1.95)、3~5月龄(RR=1.54,95%CI:1.12~2.11)和6~11月龄(RR=1.58,95%CI:1.17~2.14)抗生素使用是18~23月龄过敏症状的危险因素。
临床怎么用
- 在婴儿期尤其是1岁内应尽量避免不必要的抗生素使用,以降低后续过敏症状风险。
- 对曾使用抗生素的婴幼儿可在6~11月龄和18~23月龄关注过敏症状的发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the associations between prenatal and 1-year-old exposure to antibiotics and allergic symptoms in children aged 6-11 months and 18-23 months. Methods: In this study, a prospective birth cohort study was adopted. A total of 2 122 pregnant women were enrolled in Maternal and Child Health Care Center of Ma'anshan from June 2015 to June 2016, and they were followed up from the beginning of pregnancy to children's 24 months of age. Excluding 564 pairs of mothers and children who were lost to follow-up or with incomplete information on the use of antibiotics and children's allergic symptoms, a total of 1 558 pairs of mothers and children were included in the analysis of this study. The parents and children's general demographic information, early-life antibiotic exposure and other data were collected, the information about allergic symptoms in children aged 6-11 months and 18-23 months were investigated by reference to the "International Study of Asthma and Allergies in Childhood (ISAAC)". The univariate and multivariate binary unconditional logistic regression model was used to was used to estimate associations between the effects of early-life antibiotic exposure on allergic symptoms in 2-year-old children. Results: The antibiotic usage rate of pregnant women during pregnancy was 3.4% (53), and the antibiotic usage rates of children between 0 to 2 months, 3 to 5 months, and 6 to 11 months were separately 15.2%(237), 15.5%(242) and 17.3%(269). The total prevalence of allergic diseases in children aged 6 to 11 months was 24.1% (375 children), and the total prevalence of allergic diseases in children aged 18 to 23 months was 22.0% (342 children). After adjust parental (maternal) education level, family monthly income per capita, parental (maternal) allergy history, parental (maternal) age at pregnancy, mother's Body Mass Index (BMI) before pregnancy, exposure to second-hand smoke during pregnancy, delivery method, child gender, birth weight, preterm birth, the use of antibiotics when children were 3-5 months old (RR=1.61,95%CI:1.19-2.17) and 6-11 months old (RR=1.43,95%CI:1.06-1.93) were the risk factors for allergic symptoms at 6-11 months of age; and the use of antibiotics when children were 0-2 months old (RR=1.41, 95%CI: 1.03-1.95), 3-5 months old (RR=1.54, 95%CI: 1.12-2.11) and 6-11 months old (RR=1.58, 95%CI: 1.17-2.14) were the risk factors for allergic symptoms at 18-23 months of age. Conclusion: Children's exposure to antibiotics within 1 year of age was a risk factor for allergic symptoms in children aged 6-11 months and 18-23 months, children should avoid unnecessary antibiotic use in infancy. 目的: 分析母亲孕期及儿童1岁内抗生素暴露和6~11月龄、18~23月龄儿童过敏性疾病的相关性。 方法: 采用前瞻性出生队列研究,2015年6月至2016年6月在马鞍山市妇幼保健院纳入2 122名孕妇,从孕期开始一直随访至儿童24月龄。排除失访及抗生素用药史、儿童过敏性疾病信息不完整的母子564对,共有1 558对母子纳入本次研究分析。收集父母及儿童一般人口学信息、生命早期抗生素暴露情况等资料,参考“国际间儿童哮喘及其他过敏性疾病的对比研究(ISAAC)”调查6~11月龄和18~23月龄儿童过敏性疾病信息。采用单因素和多因素二分类非条件logistic回归模型分析生命早期抗生素暴露对6~11月龄和18~23月龄儿童过敏性疾病的影响。 结果: 孕妇孕期抗生素使用率为3.4%(53名),儿童在0~2月龄、3~5月龄、6~11月龄的抗生素使用率分别为15.2%(237名)、15.5%(242名)、17.3%(269名)。6~11月龄儿童过敏性疾病总患病率为24.1%(375名),18~23月龄儿童过敏性疾病总患病率为22.0%(342名)。在调整父(母)亲文化程度、家庭人均月收入、父(母)亲过敏史、妊娠时父(母)亲年龄、母亲孕前体重指数(BMI)、孕期是否接触二手烟、分娩方式、儿童性别、出生体重、是否早产后,儿童3~5月龄使用抗生素(RR=1.61,95%CI:1.19~2.17)和6~11月龄使用抗生素(RR=1.43,95%CI:1.06~1.93)是6~11月龄儿童过敏性疾病发生的危险因素;儿童0~2月龄使用抗生素(RR=1.41,95%CI:1.03~1.95)、3~5月龄使用抗生素(RR=1.54,95%CI:1.12~2.11)和6~11月龄使用抗生素(RR=1.58,95%CI:1.17~2.14)是18~23月龄儿童过敏性疾病发生的危险因素。 结论: 儿童1岁内抗生素暴露是其在6~11月龄和18~23月龄发生过敏性疾病的危险因素,儿童在婴儿期应尽量避免不必要的抗生素使用。.
引用
- Jiang L, Xie LL, Yan SQ, et al. [Effect of early-life antibiotic exposure on allergic symptoms in children aged 6-11 months and 18-23 months based a birth cohort study]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021. PMID: 34034399. doi:10.3760/cma.j.cn112150-20210316-00257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。